Bioanalysis

Bioanalysis

IBS is the name doctors have given to conditions characterized by cramp like abdominal pains, bloating and bouts of diarrhea and/or constipation. According to an article in Nature, it affects hundreds of millions of people — around 11% of the global population has IBS, with a higher prevalence in North America. As a result, there is a significant need for treatments.


As part of Irritable Bowel Syndrome (IBS) awareness month, we wanted to provide you with insight into potential IBS treatments.


“Patient centricity” is the process of designing a service or solution around the patient; more specifically, it is collectively defined as “Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best experience and outcome for that person and their family.

It is important that patient-centric approaches be applied in all research activities, including bioanalysis.